Equilibrium-binding affinities of ligands for a drug target do not always accurately reflect the success of drug candidates in the clinic. Affinity-based predictions concerning competitive antagonism on the target will only be accurate if equilibrium binding of both ligands is allowed. Unless equilibrium for ligand bind- ing is obtained really quickly, it is unlikely that equilibrium is established in vivo. Instead, concentrations of (endogenous) ligands rapidly fluctuate over time. Hence, the velocity in which binding equilibrium is reached and the duration of target occupancy by the ligand (also known as residence time) are thought to be more important predictors of drug in vivo efficacy. This chapter provides the theoretical background o...
International audienceIn the early stage of a drug discovery process, the selection and optimization...
While drug discovery programs are traditionally focused on equilibrium-based par...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...
The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (...
Over the past decade the kinetics of ligand binding to a receptor have received increasing interest....
Ligand residence time is thought to be a critical parameter for optimizing the in vivo efficacy of d...
The kinetics of drug binding and unbinding is assuming an increasingly crucial role in the long, cos...
There is an increasing interest in guiding hit optimization by considering the target binding kineti...
INTRODUCTION\nDrug-target binding kinetics are major determinants of the time course of drug actio...
It is generally accepted that, in conjunction with pharmacokinetics, the first-order rate constant o...
© 2019, The Author(s). Drug-target binding kinetics are suggested to be important parameters for the...
Residence time describes the how long a ligand is bound to its target, and is attracting interest in...
In the last three decades, protein and nucleic acid structure determination and comprehension of the...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...
An important question in drug discovery is how to overcome the significant challenge of high drug at...
International audienceIn the early stage of a drug discovery process, the selection and optimization...
While drug discovery programs are traditionally focused on equilibrium-based par...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...
The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (...
Over the past decade the kinetics of ligand binding to a receptor have received increasing interest....
Ligand residence time is thought to be a critical parameter for optimizing the in vivo efficacy of d...
The kinetics of drug binding and unbinding is assuming an increasingly crucial role in the long, cos...
There is an increasing interest in guiding hit optimization by considering the target binding kineti...
INTRODUCTION\nDrug-target binding kinetics are major determinants of the time course of drug actio...
It is generally accepted that, in conjunction with pharmacokinetics, the first-order rate constant o...
© 2019, The Author(s). Drug-target binding kinetics are suggested to be important parameters for the...
Residence time describes the how long a ligand is bound to its target, and is attracting interest in...
In the last three decades, protein and nucleic acid structure determination and comprehension of the...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...
An important question in drug discovery is how to overcome the significant challenge of high drug at...
International audienceIn the early stage of a drug discovery process, the selection and optimization...
While drug discovery programs are traditionally focused on equilibrium-based par...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...